A measurement can be scientifically interesting without being ready to diagnose a person or substantiate a treatment claim. The source map explicitly separates research services from clinical biological-age interpretation and consumer rejuvenation promises. That boundary is part of the proposed product design, not fine print added after a sale.
Begin with the intended use
A research result may help a developer choose an experiment. A result used to diagnose, predict an individual’s health risk or guide treatment has a different purpose. The intended use matters; a label alone does not transform a clinical use into a nonclinical one. FDA’s research-use guidance should be reviewed with qualified advisers for a proposed product.
Separate the measurement from the benefit
A molecular clock, a senescence-associated readout and a functional endpoint describe different outcomes. A marker shift does not itself demonstrate longer life or better patient function. The existing Atlas keeps these distinctions visible in its individual study briefs rather than presenting one universal age-reversal score.
Match a claim to the evidence
The exact statement matters. A cultured-cell observation is not the same claim as a benefit in consumers. FTC guidance addresses the evidence needed for health-product advertising. A “clinically proven” badge cannot be inferred simply because an experiment produced a favorable marker.
Build the distinction into deliverables
An Evidence Sprint should label models and access limits. A Cell-State Panel should preserve uncertainty and discordant findings. A skin evidence package should identify the additional work a broader claim would need. These are scoping principles, not a representation that Karam provides clinical interpretation or legal clearance.
Know what this site is not offering
Karam’s public tools are research planning and arithmetic utilities. The commercial pages do not offer treatment selection, patient testing or a personal biological-age diagnosis. Initial inquiries should omit health records and sensitive personal information.
The practical takeaway: Define the use, inspect the evidence and obtain appropriate review before extending a research finding into a health claim.